Britain's Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition.
Vectura drops severe asthma treatment after poor trial results
Reviewed by jenisht
on
November 26, 2018
Rating: 5
No comments: